Trial Profile
Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Jul 2021
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- 03 Aug 2018 Status changed from active, no longer recruiting to completed.
- 12 Mar 2018 Status changed to active, no longer recruiting as per result presented at the 67th Annual Scientific Session of the American College of Cardiology
- 12 Mar 2018 Results presented at the 67th Annual Scientific Session of the American College of Cardiology